- Home
- Signaling Pathways
- L-NAME hydrochloride
- Home
- Signaling Pathways
- Others
- L-NAME hydrochloride
- Home
- Signaling Pathways
- Others
- nNOS
- L-NAME hydrochloride
- Home
- Amino Acids & Building Blocks
- Amino Acids and Derivatives
- L-NAME hydrochloride
L-NAME hydrochloride
L-NAME Hydrochloride is an inhibitor of nitric oxide synthase (NOS) with IC50 value of 70 μM [1].?
NOS is an important enzyme involved in production of NO. NO, the smallest signaling molecule known, controls servoregulatory functions such as neurotransmission or vascular tone, regulates gene transcription and mRNA translation, as well as produces post-translational modifications of proteins [2].?
At concentrations of 10-9 ~ 10-3 M, L-NAME Hydrochloride inhibited NOS purified from rat brains in a dose dependent manner, with IC50 value of 70 μM [1]. In another study, L-NAME Hydrochloride at 0.1 ~ 100 mM caused concentration-dependent inhibition of the Ca2+-dependent endothelial NO synthase from porcine aortae. L-NAME Hydrochloride also caused an endothelium-dependent contraction and an inhibition of the endothelium-dependent relaxation induced by acetylcholine (ACh) in aortic rings [3].?
In anaesthetized rats, L-NAME Hydrochloride (0.03 ~ 300 mg/kg, i.v.) induced a dose-dependent increase in mean systemic arterial blood pressure accompanied by bradycardia. L-NAME Hydrochloride (100 mg/kg, i.v.) significantly inhibited the hypotensive responses to ACh and bradykinin. The increase in blood pressure and bradycardia produced by L-NAME Hydrochloride could be reversed by L-arginine (30 ~ 100 mg/kg, i.v.) in a dose-dependent manner [3].?
References:
[1]. Pfeiffer S, Leopold E, Schmidt K, et al. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine. British Journal of Pharmacology, 1996, 118(6): 1433-1440.
[2]. F?rstermann U, Sessa W C. Nitric oxide synthases: regulation and function. European Heart Journal, 2012, 33(7): 829-837.
[3]. Rees D D, Palmer R M, Schulz R, et al. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. British Journal of Pharmacology, 1990, 101(3): 746-752.
- 1. Yong Fan, et al. "Nitric oxide-induced lipophagic defects contribute to testosterone deficiency in rats with spinal cord injury." Front Endocrinol (Lausanne). 2024 Feb 22:15:1360499. PMID: 38455652
- 2. Jie Wu, Pingfan Guo, et al. "Glucagon-like peptide-1 affects human umbilical vein endothelial cells in high glucose by the PI3K/Akt/eNOS signaling pathway." Turk J Biochem. 2017 09 11.
Physical Appearance | A solid |
Storage | Store at -20°C |
M.Wt | 269.7 |
Cas No. | 51298-62-5 |
Formula | C7H15N5O4·HCl |
Synonyms | L-NAME, L-NAME HCL |
Solubility | ≥27 mg/mL in H2O; insoluble in EtOH; ≥23 mg/mL in DMSO |
Chemical Name | methyl (2S)-2-amino-5-[[amino(nitramido)methylidene]amino]pentanoate;hydrochloride |
SDF | Download SDF |
Canonical SMILES | COC(=O)C(CCCN=C(N)N[N+](=O)[O-])N.Cl |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Cell experiment:[1] | |
Cell lines |
Bovine retinal endothelial cells (BRECs) and rat retinal müller cell line rMC-1 |
Reaction Conditions |
1 mM L-NAME for 5 d incubation |
Applications |
L-NAME inhibited production of NO and prostaglandin E2 as well as expression of iNOS and COX-2 in rMC-1 cells exposed to 25 mM glucose. Moreover, L-NAME also reduced BREC and rMC-1 cell death in the high glucose condition. |
Animal experiment:[2] | |
Animal models |
Male Wistar rats, 200 ~ 300 g |
Dosage form |
0.03 ~ 300 mg/kg Intravenous administration (i.v.) |
Applications |
L-NAME (0.03 ~ 300 mg/kg, i.v.) induced a dose-dependent increase in mean systemic arterial blood pressure accompanied by bradycardia. Furthermore, L-NAME (100 mg/kg, i.v.) inhibited significantly the hypotensive responses to acetylcholine and bradykinin. The increases in blood pressure and bradycardia produced by L-NAME were reversed by L-arginine (30 ~ 100 mg/kg, i.v.) in a dose-dependent manner. Therefore, L-NAME could be used to study the important role of NO synthesis in the maintenance of vascular tone and blood pressure. |
Note |
The technical data provided above is for reference only. |
References: 1. Du Y, Sarthy VP, Kern TS. Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004, 287(4): R735-741. 2. Rees DD, Palmer RM, Schulz R, et al. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. British Journal of Pharmacology, 1990, 101(3): 746-752. |
Description | L-NAME hydrochloride is a NO synthase inhibitor. | |||||
Targets | ||||||
IC50 |
Quality Control & MSDS
- View current batch: